Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Archives of Toxicology|December 20, 2002
Children as a special population at risk--quinolones as an example for xenobiotics exhibiting skeletal toxicityRalf StahlmannDrugs & Aging|March 10, 2010
Safety considerations of fluoroquinolones in the elderly: an updateRalf Stahlmann, Hartmut LodeDrugs & Aging|March 19, 2003
Fluoroquinolones in the elderly: safety considerationsRalf Stahlmann, Hartmut LodeArchives of Toxicology|June 18, 2003
Ultrastructural changes induced by the des-F(6)-quinolone garenoxacin (BMS-284756) and two fluoroquinolones in Achilles tendon from immature ratsMehdi Shakibaei, Ralf StahlmannMedizinische Monatsschrift Fur Pharmazeuten|February 2, 2013
[The eye as target of adverse ocular drug reactions. Focus on systemic antiinfective therapy]Matthias Huber, Ralf StahlmannMedizinische Monatsschrift Fur Pharmazeuten|November 5, 2009
[Nephrogenic systemic fibrosis]Astrid Breitschaft, Ralf StahlmannDeutsche Medizinische Wochenschrift (1946)|February 24, 2015
[Pharmacokinetics of antibiotics in obese and critical care patients]Ralf Stahlmann, Hartmut LodeGMS Infectious Diseases|May 7, 2020
Calculated initial parenteral treatment of bacterial infections: Safety and tolerabiltyRalf Stahlmann, Hartmut LodeDeutsches Arzteblatt International|April 29, 2020
Medication for COVID-19-an Overview of Approaches Currently Under StudyRalf Stahlmann, Hartmut LodePageof 7